Synagis Pregnancy Warnings
Animal studies have not been reported. There are no controlled data in human pregnancy.
US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
This drug is not indicated for adult use.
AU TGA pregnancy category: Not assigned
US FDA pregnancy category: C
Comment:
-It is not known whether this drug can cause fetal harm when administered to a pregnant woman or could affect reproductive capacity.
See references